• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Coonrad-Morrey全肘关节置换术中肱骨干假体的无菌性松动率。尺寸重要吗?

Aseptic loosening rate of the humeral stem in the Coonrad-Morrey total elbow arthroplasty. Does size matter?

作者信息

Puskas Gabor J, Morrey Bernard F, Sanchez-Sotelo Joaquin

机构信息

Belgrist University, Zürich, Swizerland.

Department of Orthopedic Surgery, Mayo Clinic, Rochester, MN, USA.

出版信息

J Shoulder Elbow Surg. 2014 Jan;23(1):76-81. doi: 10.1016/j.jse.2013.08.025.

DOI:10.1016/j.jse.2013.08.025
PMID:24331123
Abstract

BACKGROUND

Aseptic implant loosening is one of the most common complications leading to revision surgery in total elbow arthroplasty. Different humeral stem lengths are available with varying designs. In general, the decision of which stem length to use depends on the surgical diagnosis or simply the surgeon preference. Often, the longer stem is used for post-traumatic or revision cases while for rheumatoid patients the shorter stem is preferred. There are no data in the literature to favor one humeral stem size over the other according to the diagnosis.

METHODS

We analyzed the total elbow joint database of the Coonrad-Morrey design at our institution for aseptic loosening leading to revision and compared the revision rate and the survival of the 4- and 6-inch humeral stems.

RESULTS

Overall, revision for aseptic humeral loosening is infrequent and occurred in only 16 of 711 total elbow arthroplasties during a mean follow-up of 88 months. There was no significant difference in the revision rate between the 2 stem lengths (1.9% for the 4-inch stems and 2.6% for the 6-inch stem).

CONCLUSION

Revision rate was correlated to the surgical diagnosis and was significantly higher for post-traumatic patients than for rheumatoid patients (5.1% vs 0.66%, P < .001). Of interest, and possibly not surprising, the mean time to revision was shorter for the 4-inch stems than it was for the 6-inch stems (37 vs 95 months, P = .034).

摘要

背景

无菌性植入物松动是全肘关节置换术中导致翻修手术的最常见并发症之一。不同的肱骨干长度有多种设计。一般来说,选择使用哪种长度的肱骨干取决于手术诊断或仅仅是外科医生的偏好。通常,较长的肱骨干用于创伤后或翻修病例,而类风湿性关节炎患者则更喜欢较短的肱骨干。文献中没有数据表明根据诊断情况某一种肱骨干尺寸优于另一种。

方法

我们分析了本机构采用Coonrad - Morrey设计的全肘关节数据库中因无菌性松动导致翻修的情况,并比较了4英寸和6英寸肱骨干的翻修率及生存率。

结果

总体而言,无菌性肱骨松动的翻修情况并不常见,在平均88个月的随访期间,711例全肘关节置换术中仅有16例发生。两种肱骨干长度的翻修率无显著差异(4英寸肱骨干为1.9%,6英寸肱骨干为2.6%)。

结论

翻修率与手术诊断相关,创伤后患者的翻修率显著高于类风湿性关节炎患者(5.1%对0.66%,P <.001)。有趣的是,可能也并不令人惊讶,4英寸肱骨干的平均翻修时间比6英寸肱骨干短(37个月对95个月,P =.034)。

相似文献

1
Aseptic loosening rate of the humeral stem in the Coonrad-Morrey total elbow arthroplasty. Does size matter?Coonrad-Morrey全肘关节置换术中肱骨干假体的无菌性松动率。尺寸重要吗?
J Shoulder Elbow Surg. 2014 Jan;23(1):76-81. doi: 10.1016/j.jse.2013.08.025.
2
[Total elbow replacement in patients with rheumatoid arthritis].[类风湿性关节炎患者的全肘关节置换术]
Acta Chir Orthop Traumatol Cech. 2011;78(5):423-30.
3
Revision Total Elbow Arthroplasty with the Semiconstrained Coonrad/Morrey Prosthesis: Follow-up to 21 Years.使用半限制性Coonrad/Morrey假体进行全肘关节置换翻修术:长达21年的随访
J Bone Joint Surg Am. 2021 Apr 7;103(7):618-628. doi: 10.2106/JBJS.20.00889.
4
Impaction grafting in revision total elbow arthroplasty due to aseptic loosening and bone loss.在因无菌性松动和骨丢失导致的翻修全肘置换术中的嵌压植骨。
J Bone Joint Surg Am. 2013 Jun 5;95(11):e741-7. doi: 10.2106/JBJS.K.01737.
5
Results with a minimum of 10 years follow-up of the Coonrad/Morrey total elbow arthroplasty.随访时间至少 10 年的 Coonrad/Morrey 全肘关节置换的结果。
Orthop Traumatol Surg Res. 2013 Oct;99(6 Suppl):S337-43. doi: 10.1016/j.otsr.2013.07.002. Epub 2013 Aug 9.
6
Outcome of total elbow replacement for rheumatoid arthritis: single surgeon's series with Souter-Strathclyde and Coonrad-Morrey prosthesis.类风湿性关节炎全肘置换术的结果:Souter-Strathclyde 和 Coonrad-Morrey 假体的单外科医生系列。
J Shoulder Elbow Surg. 2010 Apr;19(3):376-83. doi: 10.1016/j.jse.2009.09.016. Epub 2010 Jan 13.
7
Experience with the Coonrad-Morrey total elbow arthroplasty: 78 consecutive total elbow arthroplasties reviewed with an average 5 years of follow-up.科纳德-莫雷全肘关节置换术的经验:78 例连续全肘关节置换术的回顾,平均随访 5 年。
J Shoulder Elbow Surg. 2013 Nov;22(11):1461-8. doi: 10.1016/j.jse.2013.07.042.
8
What factors can reduce the need for repeated revision for humeral loosening in revision total elbow arthroplasty?哪些因素可减少翻修全肘关节置换术后肱骨干松动的再次翻修需求?
J Shoulder Elbow Surg. 2023 Jul;32(7):1514-1523. doi: 10.1016/j.jse.2023.03.003. Epub 2023 Mar 31.
9
Outcomes of total elbow arthroplasty for rheumatoid arthritis: comparative study of three implants.类风湿性关节炎全肘关节置换术的疗效:三种植入物的比较研究
J Bone Joint Surg Am. 2005 Nov;87(11):2439-48. doi: 10.2106/JBJS.D.02927.
10
Coonrad-Morrey total elbow arthroplasty for patients with rheumatoid arthritis: 54 prostheses reviewed at 7 years' average follow-up (maximum, 16 years).科纳德-莫雷全肘关节置换术治疗类风湿关节炎患者:7 年平均随访(最长 16 年)时 54 例假体的回顾。
J Shoulder Elbow Surg. 2018 Mar;27(3):398-403. doi: 10.1016/j.jse.2017.11.007. Epub 2018 Jan 4.

引用本文的文献

1
Anatomical references for optimizing rotational alignment of the humeral component in total elbow arthroplasty with bone loss.在存在骨缺损的全肘关节置换术中优化肱骨假体旋转对线的解剖学参考。
Sci Rep. 2025 Jul 2;15(1):23449. doi: 10.1038/s41598-025-05973-3.
2
Prognostic factors associated with failure of total elbow arthroplasty.与全肘关节置换术失败相关的预后因素。
Bone Joint Res. 2024 May 1;13(5):201-213. doi: 10.1302/2046-3758.135.BJR-2023-0281.R1.
3
Total Elbow Arthroplasty in Young Patients - An 8-Year Follow-up Case Series.
年轻患者的全肘关节置换术——一项8年随访病例系列研究
J Orthop Case Rep. 2023 Dec;13(12):58-62. doi: 10.13107/jocr.2023.v13.i12.4078.
4
Complications of modern design total elbow replacement.现代设计全肘关节置换的并发症。
J Clin Orthop Trauma. 2021 May 15;19:42-49. doi: 10.1016/j.jcot.2021.05.008. eCollection 2021 Aug.
5
Treatment of complete ankylosed elbow with total arthroplasty.全肘关节置换术治疗完全强直的肘关节。
BMJ Case Rep. 2019 Jul 21;12(7):e231123. doi: 10.1136/bcr-2019-231123.